KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Xenon Pharmaceuticals (XENE) Preferred Shares: 2013-2021

Historic Preferred Shares for Xenon Pharmaceuticals (XENE) over the last 4 years, with Dec 2021 value amounting to $7.7 million.

  • Xenon Pharmaceuticals' Preferred Shares changed negligibly% to $7.7 million in Q4 2021 from the same period last year, while for Dec 2021 it was $7.7 million, marking a year-over-year negligible change of negligibly%. This contributed to the annual value of $7.7 million for FY2021, which is negligibly% changed negligibly from last year.
  • According to the latest figures from FY2021, Xenon Pharmaceuticals' Preferred Shares is $7.7 million, which was down 0.00% from $7.7 million recorded in FY2020.
  • In the past 5 years, Xenon Pharmaceuticals' Preferred Shares ranged from a high of $7.7 million in FY2019 and a low of $7.7 million during FY2019.
  • In the last 3 years, Xenon Pharmaceuticals' Preferred Shares had a median value of $7.7 million in 2021 and averaged $7.7 million.